Profile: World Heart Inc. is a provider of implantable heart-assist devices. Our Novacor II LVAS is designed to be a miniaturized implantable assist device just half the size of its predecessor, building on the proven Novacor technology & is intended for long-term support of patients with heart failure. Our mechanical circulatory support devices assist the failing heart to pump blood. These pumps are also called ventricular assist devices (VADs). The VADs are used to support the left ventricle, which takes oxygenated blood from the lungs and pumps it through the tissues and organs. As a result of this heavy and constant demand, the left ventricle does most of the pumping work and therefore fails more often. Long-term support of the left ventricle alone is estimated to serve more than 80% of eligible patients. In addition, we also develop magnetically levitated rotary pump & rotary VADs to treat the full spectrum needs of end-stage and late-stage heart failure patients.

The company was founded in 1969, has revenues of USD 1-5 Million, has ~20 employees and is ISO 9001 certified. NASDAQ:WHRT (SEC Filings)